Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-117-7
CAS number: 103-49-1
Pharmacokinetics of dibenzylamine was investigated by an intramuscular
injection of 1250 mg of a cefazoline-dibenzylamine-complex into 3
volunteers.Blood and urine content was measured chromatographically in
time intervals up to at least 36 hours.The following determinations were
made: absorption rate constant .33 per hour; half-life of dibenzylamine:
6.33 hours; t(max): 5.23 hours;
C( max): 141.6 ng/ml; Area Under the Curve (AUC): 2296.5 ng h/ml;
urinary excretion: 6.73 %
According to these findings and using the normal dosage interval of 24
h, the degree of accumulation of dibenzylamine between the first dose
and the steady state would be 1.07 (Calvo 1989)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again